<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Neuroscientific Biopharmaceuticals Ltd. — News on 6ix</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd</link>
<description>Latest news and press releases for Neuroscientific Biopharmaceuticals Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 25 May 2026 23:51:05 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/neuroscientific-biopharmaceuticals-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683667b378dffbe2df15e6fc.webp</url>
<title>Neuroscientific Biopharmaceuticals Ltd.</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd</link>
</image>
<item>
<title>Remarkable Results from Patients treated with StemSmart</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/remarkable-results-from-patients-treated-with-stemsmart</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/remarkable-results-from-patients-treated-with-stemsmart</guid>
<pubDate>Mon, 25 May 2026 23:51:05 GMT</pubDate>
<description>Remarkable Results from Patients treated with StemSmart</description>
</item>
<item>
<title>Half Yearly Report and Accounts</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/half-yearly-report-and-accounts-296</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/half-yearly-report-and-accounts-296</guid>
<pubDate>Wed, 25 Feb 2026 13:21:03 GMT</pubDate>
<description>Half Yearly Report and Accounts</description>
</item>
<item>
<title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-93</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-93</guid>
<pubDate>Fri, 30 Jan 2026 02:48:16 GMT</pubDate>
<description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Successful Clinical Results Achieved under Special Access</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/successful-clinical-results-achieved-under-special-access</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/successful-clinical-results-achieved-under-special-access</guid>
<pubDate>Tue, 13 Jan 2026 04:12:04 GMT</pubDate>
<description>Successful Clinical Results Achieved under Special Access</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/trading-halt-684</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/trading-halt-684</guid>
<pubDate>Fri, 09 Jan 2026 03:48:12 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>Fourth Patient Commences StemSmart MSC Treatment</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/fourth-patient-commences-stemsmart-msc-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/fourth-patient-commences-stemsmart-msc-treatment</guid>
<pubDate>Tue, 11 Nov 2025 03:47:05 GMT</pubDate>
<description>Fourth Patient Commences StemSmart MSC Treatment</description>
</item>
<item>
<title>2025 Annual Report & Appendix 4E</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/2025-annual-report-and-appendix-4e-5</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/2025-annual-report-and-appendix-4e-5</guid>
<pubDate>Thu, 28 Aug 2025 11:43:25 GMT</pubDate>
<description>2025 Annual Report & Appendix 4E</description>
</item>
<item>
<title>Previous StemSmart Studies Support Renal Transplantation</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/previous-stemsmart-studies-support-renal-transplantation</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/previous-stemsmart-studies-support-renal-transplantation</guid>
<pubDate>Wed, 27 Aug 2025 04:10:18 GMT</pubDate>
<description>Previous StemSmart Studies Support Renal Transplantation</description>
</item>
<item>
<title>Experienced Cell Therapy Executive Appointed CEO</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/experienced-cell-therapy-executive-appointed-ceo</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/experienced-cell-therapy-executive-appointed-ceo</guid>
<pubDate>Mon, 28 Jul 2025 03:40:15 GMT</pubDate>
<description>Experienced Cell Therapy Executive Appointed CEO</description>
</item>
<item>
<title>StemSmart Acquisition Complete</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/stemsmart-acquisition-complete</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/stemsmart-acquisition-complete</guid>
<pubDate>Fri, 27 Jun 2025 03:51:20 GMT</pubDate>
<description>StemSmart Acquisition Complete</description>
</item>
<item>
<title>Previous StemSmart Studies Demonstrate Clinical Response</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/previous-stemsmart-studies-demonstrate-clinical-response</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/previous-stemsmart-studies-demonstrate-clinical-response</guid>
<pubDate>Thu, 19 Jun 2025 03:46:06 GMT</pubDate>
<description>Previous StemSmart Studies Demonstrate Clinical Response</description>
</item>
<item>
<title>NeuroScientific to Acquire Leading Stem Cell Technology</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/neuroscientific-to-acquire-leading-stem-cell-technology</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/neuroscientific-to-acquire-leading-stem-cell-technology</guid>
<pubDate>Wed, 16 Apr 2025 03:31:06 GMT</pubDate>
<description>NeuroScientific to Acquire Leading Stem Cell Technology</description>
</item>
<item>
<title>2024 Annual Report & Appendix 4E</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/2024-annual-report-and-appendix-4e-5</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/2024-annual-report-and-appendix-4e-5</guid>
<pubDate>Thu, 29 Aug 2024 13:41:10 GMT</pubDate>
<description>2024 Annual Report & Appendix 4E</description>
</item>
<item>
<title>Appointment of Executive Director & FDA Pre-Ind Meeting</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/appointment-of-executive-director-and-fda-pre-ind-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/appointment-of-executive-director-and-fda-pre-ind-meeting</guid>
<pubDate>Tue, 02 Apr 2024 02:47:36 GMT</pubDate>
<description>Appointment of Executive Director & FDA Pre-Ind Meeting</description>
</item>
<item>
<title>NSB Receives A$2.2M Research & Development Tax Refund</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/nsb-receives-adollar22m-research-and-development-tax-refund</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/nsb-receives-adollar22m-research-and-development-tax-refund</guid>
<pubDate>Wed, 20 Mar 2024 03:00:16 GMT</pubDate>
<description>NSB Receives A$2.2M Research & Development Tax Refund</description>
</item>
<item>
<title>Resignation of CEO</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/resignation-of-ceo-12</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/resignation-of-ceo-12</guid>
<pubDate>Fri, 01 Dec 2023 06:31:08 GMT</pubDate>
<description>Resignation of CEO</description>
</item>
<item>
<title>Appointment of CEO</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/appointment-of-ceo-30</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/appointment-of-ceo-30</guid>
<pubDate>Thu, 31 Aug 2023 08:13:28 GMT</pubDate>
<description>Appointment of CEO</description>
</item>
<item>
<title>2023 Annual Report and Appendix 4E</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/2023-annual-report-and-appendix-4e-3</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/2023-annual-report-and-appendix-4e-3</guid>
<pubDate>Fri, 25 Aug 2023 09:51:07 GMT</pubDate>
<description>2023 Annual Report and Appendix 4E</description>
</item>
<item>
<title>Positive treatment effect in MS animal study</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/positive-treatment-effect-in-ms-animal-study</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/positive-treatment-effect-in-ms-animal-study</guid>
<pubDate>Tue, 14 Mar 2023 04:25:09 GMT</pubDate>
<description>Positive treatment effect in MS animal study</description>
</item>
<item>
<title>R&D Tax Incentive Refund Received</title>
<link>https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/randd-tax-incentive-refund-received-1</link>
<guid isPermaLink="true">https://6ix.com/company/neuroscientific-biopharmaceuticals-ltd/news/randd-tax-incentive-refund-received-1</guid>
<pubDate>Thu, 02 Feb 2023 04:48:19 GMT</pubDate>
<description>R&D Tax Incentive Refund Received</description>
</item>
</channel>
</rss>